714 related articles for article (PubMed ID: 19686413)
21. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
[TBL] [Abstract][Full Text] [Related]
22. Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis.
Zhang DL; Hao JY; Yang N
J Int Med Res; 2013 Jun; 41(3):664-72. PubMed ID: 23637275
[TBL] [Abstract][Full Text] [Related]
23. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
24. Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis.
Dai J; Qi X; Li H; Guo X
Saudi J Gastroenterol; 2015; 21(3):165-74. PubMed ID: 26021776
[TBL] [Abstract][Full Text] [Related]
25. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
[TBL] [Abstract][Full Text] [Related]
26. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.
Amitrano L; Brancaccio V; Guardascione MA; Margaglione M; Iannaccone L; D'Andrea G; Marmo R; Ames PR; Balzano A
Hepatology; 2000 Feb; 31(2):345-8. PubMed ID: 10655256
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
28. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Value of d-Dimer, P-Selectin, and Platelet Count for Prediction of Portal Vein Thrombosis After Devascularization.
Fei Y; Zong GQ; Chen J; Liu RM
Clin Appl Thromb Hemost; 2016 Jul; 22(5):471-5. PubMed ID: 25633343
[TBL] [Abstract][Full Text] [Related]
30. Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis.
Rossetto V; Spiezia L; Senzolo M; Rodriguez K; Gavasso S; Woodhams B; Simioni P
Int J Lab Hematol; 2013 Feb; 35(1):101-5. PubMed ID: 22958499
[TBL] [Abstract][Full Text] [Related]
31. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
32. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
Hu KQ; Yu AS; Tiyyagura L; Redeker AG; Reynolds TB
Am J Gastroenterol; 2001 May; 96(5):1581-6. PubMed ID: 11374703
[TBL] [Abstract][Full Text] [Related]
33. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
34. [Prospective investigation of postoperative lower extremity deep venous thrombosis in gynecological procedures].
Liu YZ; Zhang ZY; Guo SL; He W; Zhang XR; Wang SZ; Liu CD; Li JF; Li L
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):107-10. PubMed ID: 16640859
[TBL] [Abstract][Full Text] [Related]
35. Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis.
Rossetto V; Spiezia L; Senzolo M; Rodriguez-Castro KI; Maggiolo S; Simioni P
Thromb Res; 2013 Aug; 132(2):e131-4. PubMed ID: 23810655
[TBL] [Abstract][Full Text] [Related]
36. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
Wosiewicz P; Żorniak M; Hartleb M; Barański K; Hartleb M; Onyszczuk M; Pilch-Kowalczyk J; Kyrcz-Krzemień S
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):722-729. PubMed ID: 27160816
[TBL] [Abstract][Full Text] [Related]
37. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
Wang Y; Liu Y; Han R; Zhu Z; Zhang Y; Wang X; Wang L; Shen Z
Thromb Res; 2008; 122(2):161-6. PubMed ID: 18048090
[TBL] [Abstract][Full Text] [Related]
38. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
39. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.
Tripodi A; Primignani M; Chantarangkul V; Dell'Era A; Clerici M; de Franchis R; Colombo M; Mannucci PM
Gastroenterology; 2009 Dec; 137(6):2105-11. PubMed ID: 19706293
[TBL] [Abstract][Full Text] [Related]
40. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
